is semaglutide on the shortage list Ozempic, Wegovy Officially Over FDA ends semaglutide shortage, closing

FDA Updates on GLP-1 Compounding: 2026 Status The FDAs regulatory position on compounded GLP-1 medications has evolved significantly since 2023 and continues to develop in 2026

Statistical Analysis Descriptive statistics were used to summarize baseline characteristics and outcomes

Lilly announced meaningful price cuts to its tirzepatide-based obesity drug Zepbound, reducing out-of-pocket costs on its LillyDirect platform to as low as $299 for the starter dose and $449 for higher doses, just weeks after negotiating a separate price-cut agreement with the Trump Administration to secure Medicare access and tariff relief

2.3 Pharmacodynamics The effects of oral semaglutide on fasting and post-prandial glucose and on lipid metabolism were investigated in a double-blinded crossover trial of 15 individuals with T2D